Pathologic Tumor Response to Neoadjuvant Chemoradiation Predicts Survival in Esophageal Cancer

被引:0
作者
Moeller, A. [1 ,2 ]
Qureshi, M. M. [1 ,2 ]
Yan, S. X. [2 ]
Dyer, M. A. [1 ,2 ]
Suzuki, K. [1 ,3 ]
Charlot, M. [1 ,4 ]
Everett, P. [1 ,4 ]
Litle, V. [1 ,3 ]
Truong, M. T. [1 ,2 ]
Mak, K. S. [1 ,2 ]
机构
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
[2] Boston Med Ctr, Dept Radiat Oncol, Boston, MA USA
[3] Boston Med Ctr, Dept Surg, Boston, MA USA
[4] Boston Med Ctr, Dept Med, Boston, MA USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词
D O I
10.1016/j.ijrobp.2018.07.531
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SU_9_2082
引用
收藏
页码:E35 / E36
页数:2
相关论文
共 50 条
[21]   Impact of neoadjuvant chemoradiation on pathologic response and survival of patients with locally advanced rectal cancer [J].
Conde, Sofia ;
Borrego, Margarida ;
Teixeira, Tania ;
Teixeira, Rubina ;
Corbal, Maria ;
Sa, Anabela ;
Soares, Paula .
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2010, 15 (03) :51-59
[22]   Prediction of Pathologic Complete Response to Neoadjuvant Chemoradiation in the Treatment of Esophageal Cancer Using Machine Learning [J].
Macomber, M. W. ;
Samareh, A. ;
Chaovalitwongse, W. A. ;
Bowen, S. R. ;
Patel, S. A. ;
Zeng, J. ;
Nyflot, M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02) :E699-E699
[23]   Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer [J].
Fang, Penny ;
Musall, Benjamin C. ;
Song, Jong Bum ;
Moreno, Amy C. ;
Hobbs, Brian P. ;
Carter, Brett W. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02) :E15-E15
[24]   Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer [J].
Fang, Penny ;
Musall, Benjamin C. ;
Son, Jong Bum ;
Moreno, Amy C. ;
Hobbs, Brian P. ;
Carter, Brett W. ;
Fellman, Bryan M. ;
Mawlawi, Osama ;
Ma, Jingfei ;
Lin, Steven H. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (04) :996-1001
[25]   Pre-Neoadjuvant Therapy Clinical Staging Predicts Overall Survival in Esophageal Cancer Patients with Pathologic Complete Response [J].
Gangi, A. ;
Hoffe, S. ;
Frakes, J. ;
Almhanna, K. ;
Pena, L. ;
Fontaine, J. ;
Blackham, A. ;
Pimiento, J. M. .
ANNALS OF SURGICAL ONCOLOGY, 2016, 23 :S151-S151
[26]   Fibrotic Response to Neoadjuvant Chemoradiation Predicts Survival in Human PDAC [J].
Erstad, D. ;
Sojoodi, M. ;
Taylor, M. S. ;
Farrar, C. T. ;
Axtell, A. L. ;
Rotile, N. J. ;
Jones, C. ;
Graham-O'Regan, K. A. ;
Ferreira, D. S. ;
Michelakos, T. ;
Kontos, F. ;
Chawla, A. ;
Li, S. ;
Goshal, S. ;
Chen, Y. ;
Arora, G. ;
Humblet, V. ;
Deshpande, V. ;
Bardeesy, N. ;
Ferrone, C. R. ;
Lanuti, M. ;
Tanabe, K. K. ;
Caravan, P. ;
Fuchs, B. .
ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) :S29-S29
[27]   Clinicopathological response to neoadjuvant chemoradiation strongly improves survival after resection of esophageal cancer [J].
Baier, P. ;
Makowiec, F. ;
Sick, O. ;
Opitz, O. ;
Hopt, U. T. .
ONKOLOGIE, 2010, 33 :83-83
[28]   Complete response to neoadjuvant chemoradiation therapy for esophageal cancer does not confer a survival advantage [J].
C. R. Schmidt ;
J. L. Tarpley ;
J. R. Roberts ;
A. S. Pearson ;
M. C. Kelley ;
M. Ninan ;
J. D. Berlin ;
A. B. Chakravarthy ;
R. D. Beauchamp ;
N. B. Merchant .
Annals of Surgical Oncology, 2004, 11 :S55-S55
[29]   Complete response to neoadjuvant chemoradiation therapy for esophageal cancer does not confer a survival advantage [J].
Schmidt, CR ;
Tarpley, JL ;
Roberts, JR ;
Pearson, AS ;
Kelley, MC ;
Ninan, M ;
Berlin, JD ;
Chakravarthy, AB ;
Beauchamp, RD ;
Merchant, NB .
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) :S55-S55
[30]   Pathologic complete response to neoadjuvant chemoradiation as a predictor of survival in Latin American patients with rectal cancer [J].
Calderillo-Ruiz, G. ;
Diaz, C. ;
Villanueva Dominguez, J. ;
Lopez Basave, H. ;
Carbajal-Lopez, B. ;
Ruiz-Garcia, E. ;
Herrera, M. ;
Munoz, W. ;
Itzel, V. ;
Perez Plascencia, C. .
ANNALS OF ONCOLOGY, 2022, 33 :S295-S296